Neogen (NASDAQ:NEOG) Shares Down 6.9% – Here’s Why

Shares of Neogen Corporation (NASDAQ:NEOG) were down 6.9% during mid-day trading on Friday . The company traded as low as $9.41 and last traded at $9.3360. Approximately 2,784,250 shares changed hands during mid-day trading, a decline of 18% from the average daily volume of 3,383,796 shares. The stock had previously closed at $10.03.

Key Stories Impacting Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Q3 results beat consensus — EPS of $0.09 vs. ~$0.04 estimate and revenue of $211.2M vs. ~$204.6M, showing the core business still generates demand. NEOG beats Q3 estimates
• Positive Sentiment: Company raised full‑year revenue guidance to roughly $857M–$860M, above consensus, signaling management expects recovery/strength in core areas. Press release: Q3 results & guidance
• Positive Sentiment: Food Safety segment remains a growth driver and was cited repeatedly as the source of strength on the quarter. Yahoo: Strong Q1/CY2026 numbers
• Neutral Sentiment: Earnings call emphasized a cautious transformation plan and operational stabilization efforts — management is balancing near‑term pressures with multi‑quarter fixes. Earnings call transcript
• Negative Sentiment: Gross margins and overall profitability deteriorated; headlines note a slump in margins and a very large negative net margin figure that worried investors. Zacks: Gross margin down
• Negative Sentiment: Animal Safety / non‑core areas are under strain and cited as a drag; Barron’s and others highlight third‑party setbacks and segment weakness that weighed on sentiment despite the beat. Barron’s: Guidance hike & animal safety drag
• Negative Sentiment: Supplier challenges caused a year‑over‑year revenue decline and contributed to investor concern about near‑term execution and margins. MarketWatch: Supplier challenges

Analysts Set New Price Targets

A number of equities research analysts have issued reports on NEOG shares. Piper Sandler reiterated a “neutral” rating and issued a $10.00 target price (up from $6.50) on shares of Neogen in a research report on Monday, January 12th. Guggenheim reiterated a “buy” rating and issued a $12.00 target price (up from $8.00) on shares of Neogen in a research report on Friday, January 9th. Wall Street Zen raised Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. William Blair reaffirmed a “market perform” rating on shares of Neogen in a research note on Monday, March 2nd. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neogen in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $10.67.

Neogen Stock Down 6.1%

The firm has a market cap of $2.05 billion, a P/E ratio of -3.40 and a beta of 1.97. The business’s fifty day moving average price is $10.09 and its two-hundred day moving average price is $7.99. The company has a current ratio of 3.91, a quick ratio of 2.80 and a debt-to-equity ratio of 0.38.

Neogen (NASDAQ:NEOG) last released its quarterly earnings results on Thursday, April 9th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.05. Neogen had a negative net margin of 68.47% and a positive return on equity of 2.14%. The business had revenue of $211.20 million for the quarter, compared to the consensus estimate of $204.62 million. The business’s quarterly revenue was down 4.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Neogen Corporation will post 0.38 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of NEOG. AQR Capital Management LLC grew its position in shares of Neogen by 217.0% in the first quarter. AQR Capital Management LLC now owns 52,410 shares of the company’s stock valued at $443,000 after purchasing an additional 35,878 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Neogen by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company’s stock valued at $1,125,000 after acquiring an additional 5,638 shares during the period. Jones Financial Companies Lllp grew its stake in shares of Neogen by 5,687.3% in the first quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company’s stock worth $290,000 after acquiring an additional 32,816 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Neogen by 14.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company’s stock worth $14,553,000 after buying an additional 209,990 shares in the last quarter. Finally, United Services Automobile Association acquired a new stake in Neogen during the first quarter worth $112,000. 96.73% of the stock is currently owned by institutional investors and hedge funds.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.